Agilent ٢٩ مايو ٢٠٢٦ Agilent Technologies (A) Margin Gains Reinforce Bullish Recurring Revenue Narrative After Q2 2026 Results - simplywall.st
FierceBiotech ٢٩ مايو ٢٠٢٦ ASCO: BMS’ CELMoD drug doubles PFS in ‘incredibly exciting’ ph. 3 myeloma study
FierceBiotech ٢٩ مايو ٢٠٢٦ ASCO: Lilly debuts ‘strong’ bladder cancer data for potential Padcev challenger
FierceBiotech ٢٩ مايو ٢٠٢٦ Gilead scraps lead arthritis drug from $405M MiroBio buyout in latest blow to BTLA agonist field
Endpoints News ٢٩ مايو ٢٠٢٦ David Chang to hand over the reins at Allogene; Ex-Esperion CEO gets started at Phlow
Endpoints News ٢٩ مايو ٢٠٢٦ Pfizer strikes Innovent deal worth up to $10.5B for a dozen cancer programs
Illumina ٢٩ مايو ٢٠٢٦ Illumina and SPT Labtech launch fireflyGO for automated oncology research - Yahoo Tech
Edwards Lifesciences ٢٩ مايو ٢٠٢٦ Boston Scientific’s $1.5B bet signals heart valve market battle - Modern Healthcare
FierceBiotech ٢٩ مايو ٢٠٢٦ Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation
Illumina ٢٩ مايو ٢٠٢٦ Assessing Illumina (ILMN) Valuation After Its New MRD Research Solution Expands Oncology Offering - simplywall.st
IQVIA ٢٩ مايو ٢٠٢٦ Veeva vs. IQVIA: Which Life Sciences Tech Stock Holds More Promise? - Zacks Investment Research
Roche Media ٢٩ مايو ٢٠٢٦ AstraZeneca, Roche to boost digital pathology uptake in APAC and more briefs - Healthcare IT News